Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis

Ioannis Kyriakoulis(University of Thessaly), George Ntaios(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Anastasia Adamou(University of Thessaly), David‐Dimitris Chlorogiannis(Mount Auburn Hospital), Ioannis Kardoutsos(University of Thessaly), Despoina Koukousaki(University of Minnesota), Iliana Stamatiou(University Hospital of Alexandroupolis)
European Journal of Internal Medicine
August 28, 2023
10.1016/j.ejim.2023.08.020
Cited by 27

Related Papers

Searching for Atrial Fibrillation Poststroke
|Circulation|2019|247
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
|New England Journal of Medicine|2023|217
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
|European Heart Journal|2022|138
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
|Stroke|2019|95
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
|EP Europace|2018|94